Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Synthetic Biology Market, by Application
1.4.2 Europe Synthetic Biology Market, by End-use
1.4.3 Europe Synthetic Biology Market, by Product
1.4.4 Europe Synthetic Biology Market, by Technology
1.4.5 Europe Synthetic Biology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Synthetic Biology Market by Application
4.1 Europe Healthcare Market by Country
4.2 Europe Non-healthcare Market by Country
Chapter 5. Europe Synthetic Biology Market by End-use
5.1 Europe Biotechnology and Pharmaceutical Companies Market by Country
5.2 Europe Academic and Government Research Institutes Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Synthetic Biology Market by Product
6.1 Europe Oligonucleotide/Oligo Pools and Synthetic DNA Market by Country
6.2 Europe Enzymes Market by Country
6.3 Europe Cloning Technologies Kits Market by Country
6.4 Europe Xeno-Nucleic Acids Market by Country
6.5 Europe Chassis Organism Market by Country
Chapter 7. Europe Synthetic Biology Market by Technology
7.1 Europe PCR Technology Market by Country
7.2 Europe NGS Technology Market by Country
7.3 Europe Genome Editing Technology Market by Country
7.4 Europe Bioprocessing Technology Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Synthetic Biology Market by Country
8.1 Germany Synthetic Biology Market
8.1.1 Germany Synthetic Biology Market by Application
8.1.2 Germany Synthetic Biology Market by End-use
8.1.3 Germany Synthetic Biology Market by Product
8.1.4 Germany Synthetic Biology Market by Technology
8.2 UK Synthetic Biology Market
8.2.1 UK Synthetic Biology Market by Application
8.2.2 UK Synthetic Biology Market by End-use
8.2.3 UK Synthetic Biology Market by Product
8.2.4 UK Synthetic Biology Market by Technology
8.3 France Synthetic Biology Market
8.3.1 France Synthetic Biology Market by Application
8.3.2 France Synthetic Biology Market by End-use
8.3.3 France Synthetic Biology Market by Product
8.3.4 France Synthetic Biology Market by Technology
8.4 Russia Synthetic Biology Market
8.4.1 Russia Synthetic Biology Market by Application
8.4.2 Russia Synthetic Biology Market by End-use
8.4.3 Russia Synthetic Biology Market by Product
8.4.4 Russia Synthetic Biology Market by Technology
8.5 Spain Synthetic Biology Market
8.5.1 Spain Synthetic Biology Market by Application
8.5.2 Spain Synthetic Biology Market by End-use
8.5.3 Spain Synthetic Biology Market by Product
8.5.4 Spain Synthetic Biology Market by Technology
8.6 Italy Synthetic Biology Market
8.6.1 Italy Synthetic Biology Market by Application
8.6.2 Italy Synthetic Biology Market by End-use
8.6.3 Italy Synthetic Biology Market by Product
8.6.4 Italy Synthetic Biology Market by Technology
8.7 Rest of Europe Synthetic Biology Market
8.7.1 Rest of Europe Synthetic Biology Market by Application
8.7.2 Rest of Europe Synthetic Biology Market by End-use
8.7.3 Rest of Europe Synthetic Biology Market by Product
8.7.4 Rest of Europe Synthetic Biology Market by Technology
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Geographical Expansions:
9.1.6 SWOT Analysis
9.2 Genscript Biotech Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional & Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Geographical Expansions:
9.2.6 SWOT Analysis
9.3 DNA TwoPointO Inc. (Atum)
9.3.1 Company Overview
9.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Eurofins Scientific SE
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 SWOT Analysis
9.6 OriGene Technologies, Inc.
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Twist Bioscience Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.6 SWOT Analysis
9.8 Editas Medicine, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Research & Development Expenses
9.8.4 SWOT Analysis
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 SWOT Analysis
9.10. Merck KGaA
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis
Unique Offerings 